SEE
53
3
ZTS
47
2
MAR
63
-5
HSIC
45
5
CTSH
60
-3
CRM
60
-7
SBUX
37
-2
OXY
36
-2
STX
45
-4
JBHT
56
-3
PLD
45
-5
UAL
83
-2
BMY
55
-8
NEM
40
3
ADP
65
-3
BDX
56
10
CVX
43
-3
NSC
53
-4
GT
56
-3
RL
69
-4
SEE
53
3
ZTS
47
2
MAR
63
-5
HSIC
45
5
CTSH
60
-3
CRM
60
-7
SBUX
37
-2
OXY
36
-2
STX
45
-4
JBHT
56
-3
PLD
45
-5
UAL
83
-2
BMY
55
-8
NEM
40
3
ADP
65
-3
BDX
56
10
CVX
43
-3
NSC
53
-4
GT
56
-3
RL
69
-4
Financhill
Back

Institute of Biomedical Research Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
21

MRES
Institute of Biomedical Research

Last Price:
0.0000
Seasonality Move:
50.57%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
21
Institute of Biomedical Research (MRES) is a Sell

Is Institute of Biomedical Research a Buy, Sell or Hold?

  • The current Institute of Biomedical Research [MRES] share price is $0.0042. The Score for MRES is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • MRES is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MRES Stock Price Chart

What is Institute of Biomedical Research's stock price today?

  • The Institute of Biomedical Research share price today is $0.0042
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRES is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

MRES Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 45.79 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.0043 - 0.0043) Sell
Bollinger Bands (100): (0.006 - 0.006) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

MRES Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0 Buy
20-day SMA: 0 Sell
50-day SMA: 0 Sell
200-day SMA: 0.01 Sell
8-day EMA: 0 Buy
20-day EMA: 0 Sell
50-day EMA: 0.01 Sell
200-day EMA: 0.01 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Institute of Biomedical Research Earnings Growth & MRES Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Institute of Biomedical Research Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):